Search results
Here's Why Sutro Biopharma (STRO) Is a Great 'Buy the Bottom' Stock Now
Zacks via Yahoo Finance· 3 months agoSutro Biopharma (STRO) witnesses a hammer chart pattern, indicating support found by the stock after...
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 11 months agoSutro Biopharma, Inc. (STRO) delivered earnings and revenue surprises of 12.33% and 0.33%,...
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 1 month agoSutro Biopharma (STRO) doesn't possess the right combination of the two key ingredients for a likely...
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Benzinga via Yahoo Finance· 2 years agoAstellas Pharma Inc (OTC: ALPMF) and Sutro Biopharma Inc (NASDAQ: STRO) announced a strategic...
With 74% ownership of the shares, Sutro Biopharma, Inc. (NASDAQ:STRO) is heavily dominated by...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Sutro Biopharma, Inc. (NASDAQ:STRO), then you'll have to...
Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially
Simply Wall St. via Yahoo Finance· 3 months agoThe analysts covering Sutro Biopharma, Inc. (NASDAQ:STRO) delivered a dose of negativity to...
Sutro Biopharma Inc (STRO) Reports Q3 2023 Financial Results and Business Updates
GuruFocus.com via Yahoo Finance· 7 months agoSutro Biopharma Inc (NASDAQ:STRO) released its 8-K filing on November 13, 2023, detailing...
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift...
Simply Wall St. via Yahoo Finance· 6 months agoSutro Biopharma, Inc. (NASDAQ:STRO) shares have had a really impressive month, gaining 48% after a...
New Forecasts: Here's What Analysts Think The Future Holds For Sutro Biopharma, Inc. (NASDAQ:STRO)
Simply Wall St. via Yahoo Finance· 2 years agoCelebrations may be in order for Sutro Biopharma, Inc. (NASDAQ:STRO) shareholders, with the analysts...
Investors Don't See Light At End Of Sutro Biopharma, Inc.'s (NASDAQ:STRO) Tunnel
Simply Wall St. via Yahoo Finance· 1 year agoWith a price-to-sales (or "P/S") ratio of 3.9x Sutro Biopharma, Inc. (NASDAQ:STRO) may be sending...